The major goal of the proposed research continues to be elucidation of the mechanisms involved in controlling the switch from latency to viral replication in Epstein-Barr virus (EBV) infected B lymphocytes. More specifically, this proposal focuses on the regulation of two linked EBV genes, the BZLF1 and BRLF1 genes, which are integrally involved in this switch. A central question with respect to maintenance of latency is whether the BZLF1 or BRLF1 promoters are actively repressed, or whether they merely require an 'activation"""""""" signal for promoter activity. During the previous funding period significant progress has been made identifying cis-elements within the BZLF1 promoter (Zp) involved in induction by TPA and anti-immunoglobulin. These studies also identified two cis-elements (ZIIIA and ZIIlB) in Zp involved in autoactivation by the BZLF1 gene product, Zta. In order to fully understand regulation of viral latency and induction of the lytic cycle it is critical to further characterize regulation of the BZLF1 and BRLF1 genes, and to identify and characterize those cellular factors which modulate their activities. Our proposed approach is as follows: a. Further characterization of the functional domains regulating Zp and Rp; (1) characterization of anti-Ig and butyrate inducibility of Zp and Rp; (2) functional analysis of the ZI domains in Zp; (3) characterization of cell and viral factor binding to the region from -129 to -105bp of Zp, which encompasses the Zta binding sites; (4) functional analyses of the ZII (AP1/CREB/C-EBF) domain in Zp; and (5) mapping cis-elements in Rp involved in induction; b. Generation of recombinant EBV harboring specific mutations in Zp or the BZLF1 gene; (1) incorporation of mutant Zp-reporters in the viral genome outside the BRLF1/BZLF1 locus; (2) generation of recombinant EBV with mutations within the BRLF1/BZLF1 locus; 2. Characterization and cloning of cellular transcription factors involved in regulating Zp and Rp activation; (l) analysis of cellular factors binding to functional domains in Zp and Rp; and (2) cloning cellular transcription factors involved in regulating expression of Zta and Rta; d. Investigation of the basis for variable inducibility of the lytic cycle in latently infected cell lines; (1) correlation of lytic cycle inducibility with inducibility of Zta and Rta expression; and (2) examination of cellular factors binding to cis-elements involved in regulating Zp and Rp in semipermissive versus nonpermissive cell lines.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA052004-07A1
Application #
2094534
Study Section
Experimental Virology Study Section (EVR)
Project Start
1990-04-18
Project End
1998-09-29
Budget Start
1995-09-30
Budget End
1996-09-29
Support Year
7
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Washington University
Department
Pathology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Wakeman, Brian S; Johnson, L Steven; Paden, Clinton R et al. (2014) Identification of alternative transcripts encoding the essential murine gammaherpesvirus lytic transactivator RTA. J Virol 88:5474-90
Reese, T A; Wakeman, B S; Choi, H S et al. (2014) Helminth infection reactivates latent ?-herpesvirus via cytokine competition at a viral promoter. Science 345:573-7
Gray, Kathleen S; Collins, Christopher M; Speck, Samuel H (2012) Characterization of omental immune aggregates during establishment of a latent gammaherpesvirus infection. PLoS One 7:e43196
Stahl, James A; Paden, Clinton R; Chavan, Shweta S et al. (2012) Amplification of JNK signaling is necessary to complete the murine gammaherpesvirus 68 lytic replication cycle. J Virol 86:13253-62
Paden, Clinton R; Forrest, J Craig; Tibbetts, Scott A et al. (2012) Unbiased mutagenesis of MHV68 LANA reveals a DNA-binding domain required for LANA function in vitro and in vivo. PLoS Pathog 8:e1002906
Collins, Christopher M; Speck, Samuel H (2012) Tracking murine gammaherpesvirus 68 infection of germinal center B cells in vivo. PLoS One 7:e33230
Liang, Xiaozhen; Paden, Clinton R; Morales, Francine M et al. (2011) Murine gamma-herpesvirus immortalization of fetal liver-derived B cells requires both the viral cyclin D homolog and latency-associated nuclear antigen. PLoS Pathog 7:e1002220
Paden, Clinton R; Forrest, J Craig; Moorman, Nathaniel J et al. (2010) Murine gammaherpesvirus 68 LANA is essential for virus reactivation from splenocytes but not long-term carriage of viral genome. J Virol 84:7214-24
Gray, Kathleen S; Forrest, J Craig; Speck, Samuel H (2010) The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency. J Virol 84:4946-59
Siegel, Andrea M; Rangaswamy, Udaya Shankari; Napier, Ruth J et al. (2010) Blimp-1-dependent plasma cell differentiation is required for efficient maintenance of murine gammaherpesvirus latency and antiviral antibody responses. J Virol 84:674-85

Showing the most recent 10 out of 51 publications